ELLORARXINE
LIVE

Serial Number

98055920

Owner

Nevrargenics Limited

Attorney

Ira E. Silfin

Filing Date

Jun 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ELLORARXINE Trademark

Serial Number: 98055920 • Registration: 7454536

ELLORARXINE is a trademark filed by Nevrargenics Limited on June 23, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Nevrargenics Limited

Ouse House, Unit 31a Mandale House
Durham DH11TT , GB

Entity Type: 16

Trademark Details

Filing Date

June 23, 2023

Registration Date

July 23, 2024

Published for Opposition

May 7, 2024

Goods & Services

Pharmaceutical compositions and preparations for the treatment of neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; pharmaceutical compositions and preparations for the treatment of schizophrenia, Amyotrophic lateral 15 sclerosis (ALS), Parkinson's disease, multiple sclerosis (MS), Alzheimer's disease, motor neurone disease, cognitive disorders, memory impairment, memory deficit, senile dementia, cognitive impairment, stroke, traumatic brain injury, epilepsy, and spinal cord injury; pharmaceutical compositions and preparations for the treatment of retinoic acid receptor mediated diseases; anti-inflammatory pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 15, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 15, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2023 NWOS
NEW APPLICATION ENTERED
Jun 27, 2023 NWAP